Glucagon‐like peptide 1 agonists and death from any cause in primary care setting

Mar-17

AUTHORS : Dr Krishnarajah Nirantharakumar, IOEM Building, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK – Email: K.Nirantharan@bham.ac.uk – Profile: https://www.birmingham.ac.uk/staff/profiles/applied-health/nirantharakumar-krishnarajah.aspx

JOURNAL : Diabetic Medicine

REFERENCE: 34(S1):159

DOI : 10.1111/dme.37_13304

Glucagon‐like peptide 1 agonists and death from any cause in primary care setting

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study